Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

S-1

  • You have access
    Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy for Pancreatic Cancer Is Related to the Continuation of S-1 Adjuvant Chemotherapy After Pancreatectomy
    SHINNOSUKE KAWAHARA, TORU AOYAMA, ITARU HASHIMOTO, REI KANEMOTO, NAOHIKO MATSUSHITA, MARIKO KAMIYA, YOSUKE ATSUMI, YUKIO MAEZAWA, KEISUKE KAZAMA, MASAAKI MURAKAWA, SATOSHI KOBAYASHI, MAKOTO UENO, NAOTO YAMAMOTO, TAKASHI OSHIMA, NORIO YUKAWA, AYA SAITO and SOICHIRO MORINAGA
    Anticancer Research October 2024, 44 (10) 4569-4577; DOI: https://doi.org/10.21873/anticanres.17286
  • Open Access
    Long-term Results of a Phase II Study of Neoadjuvant SOX for Advanced Gastric Cancer
    SHUNICHI ITO, HIDEKAZU KURAMOCHI, AKIKO SERIZAWA, MASAHO OTA, SATOSHI KATAGIRI, SHINSUKE MAEDA and KEI HOSODA
    Anticancer Research January 2024, 44 (1) 195-204; DOI: https://doi.org/10.21873/anticanres.16802
  • You have access
    Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
    MASAAKI YAMAMOTO, TAKESHI OMORI, NAOKI SHINNO, HISASHI HARA, YOSUKE MUKAI, TAKAHITO SUGASE, TOMOHIRA TAKEOKA, MANABU MIKAMORI, TAKASHI KANEMURA, SHINICHIRO HASEGAWA, HIROFUMI AKITA, NAOTSUGU HARAGUCHI, JUNICHI NISHIMURA, HIROSHI WADA, CHU MATSUDA, MASAYOSHI YASUI, HIROSHI MIYATA and MASAYUKI OHUE
    Anticancer Research November 2023, 43 (11) 5015-5024; DOI: https://doi.org/10.21873/anticanres.16700
  • You have access
    Neoadjuvant Modified Short-course Radiotherapy for Stage IV Rectal Cancer
    HIROSHI DOI, MASAYUKI FUJIWARA, NAOHITO BEPPU, HIROYUKI YOKOYAMA, SHOGO HARUI, AYAKO SUGIHARA, HIDENORI YANAGI, YOSHIO HISHIKAWA, NAOKI YAMANAKA and NORIHIKO KAMIKONYA
    Anticancer Research November 2022, 42 (11) 5587-5595; DOI: https://doi.org/10.21873/anticanres.16066
  • You have access
    Prognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal Adenocarcinoma
    HAJIME MATSUSHIMA, TOMOHIKO ADACHI, MASAAKI HIDAKA, MAMPEI YAMASHITA, TAKASHI HAMADA, SAEKO FUKUI, TAKAYUKI TANAKA, HAJIME IMAMURA, KYOHEI YOSHINO, TOTA KUGIYAMA, AMANE KITASATO, TAKANOBU HARA, AKIHIKO SOYAMA, KAZUMA KOBAYASHI, YORIHISA SUMIDA, TAMOTSU KUROKI and SUSUMU EGUCHI
    Anticancer Research June 2022, 42 (6) 3133-3141; DOI: https://doi.org/10.21873/anticanres.15802
  • You have access
    Preoperative S-1 Therapy for Head and Neck Carcinoma During the Waiting Period Before Surgery
    TAKASHI MATSUKI, CHIHIRO FUSHIMI, SHUNSUKE MIYAMOTO, HIDEAKI TAKAHASHI, TATSUO MASUBUCHI, YUICHIRO TADA, KOUKI MIURA, SHIN-ETSU KAMATA, KOICHI KANO, SHOHEI TSUTSUMI, KAHO MOMIYAMA and TAKU YAMASHITA
    Anticancer Research June 2022, 42 (6) 3177-3183; DOI: https://doi.org/10.21873/anticanres.15807
  • You have access
    Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen
    HIROAKI TANIOKA, KEN SHIMADA, AKIHITO TSUJI, MITSUGU KOCHI, HO MIN KIM, TAKAO TAKAHASHI, TADAMICHI DENDA, AKINORI TAKAGANE, TAKANORI WATANABE, MASAHITO KOTAKA, MASATO NAKAMURA, YU SUNAKAWA, MASAHIRO TAKEUCHI, WATARU ICHIKAWA and MASASHI FUJII
    Anticancer Research May 2022, 42 (5) 2675-2681; DOI: https://doi.org/10.21873/anticanres.15745
  • You have access
    Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study
    AKIKO TODAKA, SATOSHI NARA, FUYUHIKO MOTOI, SOICHIRO MORINAGA, REISHI TOSHIYAMA, RYOTA HIGUCHI, MASARU KONISHI, HIROFUMI SHIRAKAWA, HIDETAKA TSUMURA, HIROYUKI OKUYAMA, HIROAKI NAGANO, KAZUHIKO SHIOJI, KEISHI SUGIMACHI, AKINORI ASAGI, NOBUMASA MIZUNO and JUNJI FURUSE
    Anticancer Research February 2022, 42 (2) 893-902; DOI: https://doi.org/10.21873/anticanres.15547
  • You have access
    Efficacy and Safety of Induction Chemotherapy and/or External Beam Radiotherapy Followed by Brachytherapy in Patients With Tongue Cancer
    RYO-ICHI YOSHIMURA, KAZUMA TODA, HIROSHI WATANABE, ATSUSHI KAIDA, HIROYUKI HARADA, TAKAHIRO ASAKAGE and MASAHIKO MIURA
    Anticancer Research December 2021, 41 (12) 6259-6266; DOI: https://doi.org/10.21873/anticanres.15446
  • You have access
    Effect of Concomitant Lafutidine on Adjuvant S-1 for Head and Neck Cancer: A Comparative Study
    KOICHIRO YOSHINO, ISAKU OKAMOTO, HIROKI SATO, TAKURO OKADA, KUNIHIKO TOKASHIKI, TAKAHITO KONDO and KIYOAKI TSUKAHARA
    Anticancer Research December 2021, 41 (12) 6279-6285; DOI: https://doi.org/10.21873/anticanres.15449

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire